Blood Gene Test Shows 90% Detection Rate for Early-Stage Pancreatic Cancer

Pancreatic cancer has long been a disease of cruel timing — lethal not because it is untreatable, but because it is almost never found in time. Researchers at Kanazawa University have developed a blood test called Panregza that detects early-stage pancreatic cancer in 9 of 10 cases by reading gene expression patterns in immune cells, compared to just 1 of 10 for the standard CA19-9 marker. Where early detection leads to surgery, survival rates climb dramatically — to 100% at stage 0 in Kanazawa's own data. The question now is whether this signal, so clear in the laboratory, can hold its promis